Search Results

15 articles with title/keywords/abstract containing Merck-Frosst

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Patients with osteoporosis in Canada are set to get improved access to alendronic acid/colecalciferol

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 10-10(1)

Publisher: Adis International

Gardasil efficacy highlighted in young men

Source: Inpharma, Volume 1, Number 1665, 2008-11-22 , pp. 18-18(1)

Publisher: Adis International

The province of Quebec has announced that it will include sitagliptin [Januvia], under some reimbursement criteria

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 11-11(1)

Publisher: Adis International

The 2008 clinical type 2 diabetes guidelines from the Canadian Diabetes Association (CDA) include the new class of DPP-IV inhibitors.

Source: Inpharma, Volume 1, Number 1657, 2008-09-27 , pp. 2-2(1)

Publisher: Adis International

The 2008 clinical type 2 diabetes guidelines from the Canadian Diabetes Association (CDA) include the new class of DPP-IV inhibitors.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 563, 2008-10-04 , pp. 2-2(1)

Publisher: Adis International

Zostavax approved in Canada for prevention of shingles

Source: Inpharma, Volume 1, Number 1653, 2008-08-30 , pp. 23-23(1)

Publisher: Adis International

Aprepitant [Emend; Merck] is now available in Canada for the prevention of acute and delayed nausea and vomiting triggered by chemotherapy.

Source: Inpharma, Volume 1, Number 1610, 2007-10-20 , pp. 23-23(1)

Publisher: Adis International

Health Canada has approved Merck Frosst's montelukast [Singulair] tablets

Source: Inpharma, Volume 1, Number 1557, 2006-09-30 , pp. 22-22(1)

Publisher: Adis International

Health Canada has approved Merck Frosst's recombinant quadrivalent human papillomavirus vaccine [Gardasil]

Source: Inpharma, Volume 1, Number 1548, 2006-07-29 , pp. 23-23(1)

Publisher: Adis International

Health Canada has approved finasteride [Proscar; Merck Frosst] and doxazosin cotherapy

Source: Inpharma, Volume 1, Number 1454, 2004-09-11 , pp. 18-18(1)

Publisher: Adis International

Rizatriptan maximises work productivity in migraine

Source: Inpharma, Volume 1, Number 1406, 2003 , pp. 6-6(1)

Publisher: Adis International

Rizatriptan maximises work productivity in migraine

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 431, 2003 , pp. 5-5(1)

Publisher: Adis International

The third-generation live varicella zoster virus vaccine `Varivax III' [Merck Frosst] has been approved by Health Canada

Source: Inpharma, Volume 1, Number 1388, 2003 , pp. 22-22(1)

Publisher: Adis International

Rofecoxib [`Vioxx'; Merck Frosst Canada Ltd.] has been approved in a new indication in Canada.

Source: Inpharma, Volume 1, Number 1386, 2003 , pp. 22-22(1)

Publisher: Adis International

Once-weekly alendronic acid is more effective than daily risedronic acid in the treatment of women with postmenopausal osteoporosis

Source: Inpharma, Volume 1, Number 1338, 2002 , pp. 14-14(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A